Page last updated: 2024-12-07

castasterone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

castasterone: a brassinosteroid; RN refers to ((2alpha,3alpha,5alpha,22R,23R,24S)-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID133534
CHEBI ID23051
SCHEMBL ID991163
MeSH IDM0222240

Synonyms (16)

Synonym
LMST01030129
6-oxo-campestan-2alpha,3alpha,22r,23r-tetrol
bp 214
ergostan-6-one, 2,3,22,23-tetrahydroxy-, (2alpha,3alpha,5alpha,22r,23r,24s)-
80736-41-0
ergostan-6-one, 2,3,22,23-tetrahydroxy-, (2alpha,3alpha,5alpha,22r,23r,24s)- (9ci)
castasterone
(2a,3a,5a,22r,23r,24s)-2,3,22,23-tetrahydroxyergostan-6-one
(2alpha,3alpha,5alpha,22r,23r,24s)-2,3,22,23-tetrahydroxyergostan-6-one
(22r,23r)-2alpha,3alpha,22,23-tetrahydroxy-5alpha-campestan-6-one
CHEBI:23051
9153A34D-DE1B-45AD-8CE2-D3A272C0695A
(2r,3s,5s,8s,9s,10r,13s,14s,17r)-17-[(2s,3r,4r,5s)-3,4-dihydroxy-5,6-dimethylheptan-2-yl]-2,3-dihydroxy-10,13-dimethyl-1,2,3,4,5,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-6-one
SCHEMBL991163
DTXSID7040992
Q27109676
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant growth stimulatornull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (6)

ClassDescription
brassinosteroid
2alpha-hydroxy steroidA 2-hydroxy steroid in which the hydroxy group at position 2 has an alpha-configuration.
3alpha-hydroxy steroidA 3-hydroxy steroid in which the 3-hydroxy substituent is in the alpha-position.
22-hydroxy steroid
23-hydroxy steroid
6-oxo steroid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (6)

PathwayProteinsCompounds
brassinolide biosynthesis II025
brassinolide biosynthesis I026
brassinosteroid biosynthesis I726
brassinosteroids inactivation210
superpathway of C28 brassinosteroid biosynthesis730
brassinosteroids inactivation215
superpathway of C28 brassinosteroid biosynthesis737
brassinosteroid biosynthesis I829
Brassinolide biosynthetic pathway022

Research

Studies (54)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (3.70)18.2507
2000's24 (44.44)29.6817
2010's24 (44.44)24.3611
2020's4 (7.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.61 (24.57)
Research Supply Index4.09 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (5.08%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other56 (94.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]